Plaintiffs Reload In Cephalon Antitrust Litigation

By Richard Vanderford

Law360, New York (August 11, 2009, 7:19 PM ET) -- Plaintiffs in antitrust litigation against Cephalon Inc. have renewed their attack, with the filing of amended complaints in three suits over the pharmaceutical company's alleged conspiracy with generics makers to keep narcolepsy drug Provigil off the market.

Drug plans, wholesalers and Apotex Inc. — left out of Cephalon's alleged payout scheme to other generic-drug makers — all filed amended complaints in their suits against the Cephalon on Monday in the U.S. District Court for the Eastern District of Pennsylvania.

In a bid to simplify the case,...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles